COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 1984: Articles 19831-19840  | Next

Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand
Whitcombe, A. L., McGregor, R., Craigie, A., James, A., Charlewood, R., Lorenz, N., Dickson, J. M. J., Sheen, C. R., Koch, B., Fox-Lewis, S., McAuliffe, G., Roberts, S. A., Morpeth, S. C., Taylor, S., Webb, R. H., Jack, S., Upton, A., Ussher, J., Moreland, N. J.
10.1101/2020.12.10.20246751 — Posted: 2020-12-11
Diverse Functional Autoantibodies in Patients with COVID-19
Wang, E. Y., Mao, T., Klein, J., Dai, Y., Huck, J. D., Liu, F., Zheng, N. S., Zhou, T., Israelow, B., Wong, P., Lucas, C., Silva, J., Oh, J. E., Song, E., Perotti, E. S., Fischer, S., Campbell, M., Fournier, J. B., Wyllie, A. L., Vogels, C. B. F., Ott, I. M., Kalinich, C. C., Petrone, M. E., Watkins, A. E., Yale IMPACT Team, , Dela Cruz, C., Farhadian, S. F., Schulz, W. L., Grubaugh, N. D., Ko, A. I., Iwasaki, A., Ring, A. M.
10.1101/2020.12.10.20247205 — Posted: 2020-12-11 Discussion: Onsite | Offsite
The COVID University Challenge: a Hazard Analysis of Critical Control Points Assessment of the Return of Students to Higher Education Establishments
Edmunds, K. L., Bowater, L., Brainard, J. S., de Coriolis, J.-C., Lake, I. R., Malik, R. R., Newark, L., Ward, N., Yeoman, K., Hunter, P. R.
10.1101/2020.12.11.20247676 — Posted: 2020-12-11
Predictors of Physical and Mental Health in Healthcare Teams Working with COVID-19 patients: a scoping review protocol.
Aguirre-Duarte, N., Ovretveit, J., Kenealy, T.
10.1101/2020.12.11.20247304 — Posted: 2020-12-11
Airborne magnetic nanoparticles: environmental risk factors for the transmission of SARS-CoV-2
Martinez-Boubeta, C., Simeonidis, K.
10.1101/2020.12.10.20247130 — Posted: 2020-12-11
COVID-19 Rapid Diagnostic test results and their associations with certain factors among the residents of Balochistan.
Arif, M., Larik, E., Saeed, A., Baig, M. A., Hussain, Z., Chaudhary, A., baig, Z. I., Bugti, Z. J., Inayat, J., Muhammad, K., Abdullah, M., Khoiso, Z. A., ain, Q. u., Kakar, A., Sheikh, N.
10.1101/2020.12.07.20245076 — Posted: 2020-12-11
What positives can be taken from the COVID-19 pandemic in Australia?
Cornell, S., Nickel, B., Cvejic, E., Bonner, C., McCaffery, K. J., Ayre, J., Copp, T., Batcup, C., Isautier, J. M., Dakin, T., Dodd, R.
10.1101/2020.12.10.20247346 — Posted: 2020-12-11
Intense and Mild Wave of COVID-19 in The Gambia: a Cohort Analysis
MRCG/GG COVID-19 working group, , Roca, A.
10.1101/2020.12.10.20238576 — Posted: 2020-12-11
Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada
Vilches, T. N., Zhang, K., Van Exan, R., Langley, J. M., Moghadas, S. M.
10.1101/2020.12.10.20246827 — Posted: 2020-12-11
COVID-19 Spreading Dynamics with Vaccination - Allocation Strategy, Return to Normalcy and Vaccine Hesitancy
Shayak, B., Sharma, M. M.
10.1101/2020.12.10.20247049 — Posted: 2020-12-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).